Indivior (INDV)


INDV Share PerformanceMore

52 week high442.20 20/04/18
52 week low246.50 01/09/17
52 week change 115.90 (36.16%)
4 week volume47,255,153 25/03/18
price date1524245972

Latest NewsMore

Uncertainty over May interest rate hike supports FTSE

The FTSE 100 kept its positive momentum going amid growing uncertainty over a UK interest rate hike in May as this put...

FTSE rises amid shifting rate expectations

The FTSE 100 took advantage of weaker sterling amid growing uncertainty over a UK interest rate hike in May. Bank of E...

Indivior files new drug submission in Canada for opoid abuse treatment

Indivior said Friday it filed a new drug submission with Health Canada's Therapeutic Drugs Directorate for an opioid abu...

Indivior's SUBLOCADE NDS Accepted by Health Canada

RNS Number: 5738L Indivior PLC 20 April 2018 Indivior Announces New Drug Submission to Health Canada for SUBLOCADE ( Buprenorphine Extended-Release) Injection for the Treatment of Moderate to Severe Opioid Use Disorder Health Canada Grants Priority Review Designation for SUBLOCADE Slough, UK and Richmond, VA, 20 April 2018 - Indivior PL...

Holding(s) in Company

RNS Number: 7780K Indivior PLC 12 April 2018 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Indivior PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the notification (please ...

Director Declaration

RNS Number: 6272K Indivior PLC 11 April 2018 Indivior PLC (the 'Company') Indivior PLC confirms that Mr Daniel Tass, Senior Independent Director, was appointed as an independent director of HLS Therapeutics Inc., a specialty pharmaceutical company listed on the TSX Venture Exchange, with effect from March 14, 2018. This announcement is made in accorda...

Notice of Results

RNS Number: 4741K Indivior PLC 11 April 2018 Indivior to Announce First Quarter 2018 Results on May 2nd and Host Conference Call Slough, UK, and Richmond, VA, 11 April 2018 - Indivior PLC (LON: INDV) today announced that it will release its first quarter 2018 results on May 2ndat 12:00 p.m. London time (7:00 a.m. U.S. Eastern). The results will be available via...

Broker Forecast - Jefferies International issues a broker note on Indivior Plc

Jefferies International today reaffirms its buy investment rating on Indivior Plc (LON:INDV) and raised its price target to...

Latest discussion posts More

  • Re: Topped up

    It's make! For a stellar share today this gets very little chat coverage.
  • Re: Topped up

    The opioid decision by the FDA is today eh? Any more feelings either way. It could be a make or break.
  • Re: Topped up

    Very glad I topped up at #2.95, don't often get a 35% increase in 2 months. Thinking of top slicing, but on the whole, I think the fact that the DoJ case is well provided for, ...

Users' HoldingsMore

Users who hold Indivior also hold..

Codes & Symbols

Our secure site will be unavailable this Sunday (22nd) from 6am until the evening. Sorry for any inconvenience.